Results 161 to 170 of about 16,538,551 (301)
Advances in Materials Science and Engineering
doaj +1 more source
Biomineralization-Driven Advances in Materials Science and Biomedical Engineering. [PDF]
Guo J, Gao F, Zhang F, Zhao X, Zhao R.
europepmc +1 more source
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source
Advances in Materials Science and Engineering
doaj +1 more source
Metal-organic frameworks for biomedical applications: bridging materials science and regenerative medicine. [PDF]
Nasri N +4 more
europepmc +1 more source
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge +17 more
wiley +1 more source
Advances in Materials Science and Engineering
doaj +1 more source
From Pathology to Materials Science and Engineering: Harnessing the Amyloid State for Biotechnological Applications. [PDF]
Fallot LB +5 more
europepmc +1 more source
Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon +4 more
wiley +1 more source
Advances in Materials Science and Engineering
doaj +1 more source

